DeepMed Research

Servier

🇧🇷Brazil

Country: 🇧🇷Brazil

Ownership: Private

Established: 1954-01-01

Employees: 251

Market Cap: -

Website: https://servier.com.br

Clinical Trials

Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 Mutation

Phase 3

Recruiting

Conditions: Residual or Recurrent Grade 2 IDH Mutant Glioma

Interventions: Drug: Vorasidenib
Drug: Placebo

First Posted Date: 2025-01-17

Last Posted Date: 2025-05-06

Lead Sponsor: Servier

Target Recruit Count: 58

Registration Number: NCT06780930

Locations: 🇨🇳
Tiantan Hospital, Beijing, China
🇨🇳
The Second People's Hospital of Shenzhen, Shenzhen, Guangdong, China
🇨🇳
West China Hospital Sichuan University, Chendu, Sichuan, China

and more 14 locations

A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation

Phase 2

Active, not recruiting

Conditions: Cholangiocarcinoma Non-resectable
Cholangiocarcinoma Metastatic

Interventions: Drug: Ivosidenib

First Posted Date: 2023-10-13

Last Posted Date: 2025-01-10

Lead Sponsor: Servier

Target Recruit Count: 12

Registration Number: NCT06081829

Locations: 🇯🇵
National Cancer Center Hospital East (JPN-002), Kashiwa, Japan
🇯🇵
Kumamoto University Hospital (JPN-004), Kumamoto, Japan
🇯🇵
National Hospital Organization Shikoku Cancer Center (JPN-007), Matsuyama, Japan

and more 4 locations

Non-drug Treatment Study in Parkinson's Disease Patients and Healthy Volunteers to Collect Biological Samples in Order to Assess ex Vivo the Activity of Candidate Therapies and Develop Novel Analytical Methods for Biomarkers

Early Phase 1

Completed

Conditions: Parkinson Disease

Interventions: Other: Blood sample collection
Other: Blood sample collection and an optional cerebrospinal fluid (CSF) collection

First Posted Date: 2023-05-01

Last Posted Date: 2025-04-11

Lead Sponsor: Servier

Target Recruit Count: 45

Registration Number: NCT05837130

Locations: 🇫🇷
Hopital La Pitié Salpétrière-Institut du Cerveau et de la Moelle Epinière-CIC Neurosciences, Paris, France
🇫🇷
Centre Hospitalo-Universitaire Lille, Lille, France
🇫🇷
Centre Hospitalo-Universitaire Grenoble Alpes, La Tronche, France

and more 1 locations

Vorasidenib Expanded Access Program

Conditions: Glioma
Recurrence
Disease Attributes
Pathologic Processes
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Glandular and Epithelial

First Posted Date: 2022-10-25

Last Posted Date: 2024-11-05

Lead Sponsor: Servier

Registration Number: NCT05592743

Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginine 5mg Fixed-dose Combination in Capsule and Free Monotherapy at the Same Dose in Patients With Uncontrolled Essential Hypertension.

Phase 3

Completed

Conditions: Essential Hypertension

Interventions: Combination Product: Amlodipine 5mg + bisoprolol fumarate 5mg + perindopril arginine 5mg
Drug: Norvasc 5mg tablet
Drug: Concor 5mg tablet
Drug: Coversyl 5mg tablet

First Posted Date: 2022-03-21

Last Posted Date: 2022-08-05

Lead Sponsor: Servier

Target Recruit Count: 150

Registration Number: NCT05288400

Locations: 🇷🇺
Problems of Cardiovascular Diseases" 6 Sosnovy Bulvar St., Kemerovo, Russian Federation
🇷🇺
Autonomous non-profit organization "Medical Center "Alliance" 12 Molodezhnaya St., 12, Kirovsk, Russian Federation
🇷🇺
Regional state budget health care institution "Altai Regional Cardiological dispensary" 46 Malakhova St., Barnaul, Altai Region, Russian Federation

and more 12 locations

An Experimental Medicine Clinical Study to Compare Peripheral Immune System From Subjects Without Cancer Diagnosis and Patients With Solid Tumours.

Not Applicable

Terminated

Conditions: Immune System

Interventions: Other: blood samples

First Posted Date: 2021-11-24

Last Posted Date: 2024-02-22

Lead Sponsor: Servier

Target Recruit Count: 36

Registration Number: NCT05133128

Locations: 🇫🇷
Centre Georges Francois Leclerc, Dijon, France
🇫🇷
CIC du CHU, Dijon, France

Trifluridin/tipirACil in MeTastatIc Colorectal Cancer

Completed

Conditions: Metastatic Colorectal Cancer

First Posted Date: 2018-09-11

Last Posted Date: 2024-12-03

Lead Sponsor: Servier

Target Recruit Count: 315

Registration Number: NCT03665506

Locations: 🇩🇪
Onkologische Schwerpunktpraxis Kurfürstendamm, Berlin, Germany

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy